Navigation

Rheumatoid arthritis - adalimumab, etanercept and infliximab

Adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis

Status: History
Expected date of issue: TBC
Process: MTA
Topic area:
  • Musculoskeletal
 

NICE project team

Executive Lead: Andrew Dillon
Technical Lead: Zoe Garrett
Communications manager: Tonya Gillis
Project manager: Natalie Bemrose
Assessment Group / Evidence Review Group: West Midlands Health Technology Assessment Collaboration
Top


 

Provisional schedule

Consultation on draft scope by stakeholders: October 2004
Information meeting with consultees: 04 February 2005
Closing date for invited submissions / evidence submission: 08 June 2005
Final scope published: November 2004
1st appraisal committee meeting: 11 January 2006
2nd appraisal committee meeting: 03 October 2006
Top


 

Consultees and commentators

Consultees Commentators (no right of appeal)

Manufacturers / Sponsors

  • Abbott Laboratories Ltd (adalimumab)
  • Wyeth Pharmaceuticals (etanercept)
  • Schering-Plough Ltd (infliximab)

Patient / Carer Groups

  • Arthritis and Musculoskeletal Alliance
  • Arthritis Care
  • Arthritis Research Campaign
  • Back Care
  • Long Term Medical Conditions Alliance
  • National Rheumatoid Arthritis Society

Professional Groups

  • British Association of Spine Surgeons
  • British Health Professionals in Rheumatology
  • British Institute of Musculoskeletal Medicine
  • British Orthopaedic Association
  • British Society for Rheumatology
  • Primary Care Rheumatology Society
  • Royal College of Nursing
  • RoyalCollegeof Physicians
  • Royal Pharmaceutical Society

Others

  • Department of Health
  • Eastern HullPCT
  • SomersetCoast PCT
  • Welsh Assembly Government

General

  • Board of Community Health Councils in Wales
  • Medicines and Healthcare products Regulatory Agency (MHRA)
  • National Public Health Service for Wales
  • NHS Quality Improvement Scotland
  • British National Formulary

Comparator Manufacturers

  • Roche

Assessment Team

  • West Midlands Health Technology Assessment Collaboration
  • National Coordinating Centre for Health Technology Assessment

Associated Guideline Groups

  • None

Associated Public Health Groups

  • None

Research Groups

  • None

Top


 

Project history

Date Update
17 August 2004 Topic summary published.
25 January 2005 Project manager updated.
16 March 2005 Final protocol provided.
12 April 2005 Changes to schedule, technical elad and expected date of issue
3 October 2005 Schedule updated.
20 December 2006 Stakeholders updated.
2 March 2007 Expected date of issue to be confirmed
Top


 

Key documents

This page was last updated: 30 March 2010

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.